{"title":"Pharmacist Hypertension Management Quality Review at an Ambulatory Care Clinic.","authors":"Kayla Chonko, Sandra Axtell, Bianca Mayzel","doi":"10.1177/87551225211064240","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> A reduction of 10 mm Hg in systolic blood pressure (SBP) significantly decreases the risk of major cardiovascular disease events. Pharmacists' management of blood pressure may assist with this reduction. <b>Objective:</b> Assess the impact of pharmacist management of hypertension via a collaborative practice agreement with physicians in an ambulatory care clinic. <b>Methods:</b> The first phase of this study was a retrospective chart review of physician/nurse hypertension visits from October 2019 to August 2020. The second prospective phase consisted of pharmacist managed hypertension visits from December 2020 to January 2021. The primary outcome was the change in SBP from the beginning to the end of the study period in the prospective group. Secondary outcomes included the proportion of patients achieving their blood pressure goal and the proportion of patients adherent to all antihypertensive medications at their follow-up visits in both groups. This study was institutional review board approved. <b>Results:</b> Forty-seven patients were included and analyzed (24 in the retrospective group and 23 in the prospective group). Patients in the prospective group had an average SBP lowering of 10.83 mm Hg (<i>P</i> = .0035). Thirteen patients (56.5%) met their blood pressure goal of <130/80 mm Hg in the prospective group, compared to 5 patients (20.8%) in the retrospective group (<i>P</i> = .012). One adverse event occurred during this study. Limitations included small sample size and short duration of study. <b>Conclusion:</b> Patients had an average SBP lowering of >10 mm Hg. More patients reached a goal blood pressure of <130/80 mm Hg when managed by pharmacists.</p>","PeriodicalId":16796,"journal":{"name":"Journal of Pharmacy Technology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820044/pdf/10.1177_87551225211064240.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/87551225211064240","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: A reduction of 10 mm Hg in systolic blood pressure (SBP) significantly decreases the risk of major cardiovascular disease events. Pharmacists' management of blood pressure may assist with this reduction. Objective: Assess the impact of pharmacist management of hypertension via a collaborative practice agreement with physicians in an ambulatory care clinic. Methods: The first phase of this study was a retrospective chart review of physician/nurse hypertension visits from October 2019 to August 2020. The second prospective phase consisted of pharmacist managed hypertension visits from December 2020 to January 2021. The primary outcome was the change in SBP from the beginning to the end of the study period in the prospective group. Secondary outcomes included the proportion of patients achieving their blood pressure goal and the proportion of patients adherent to all antihypertensive medications at their follow-up visits in both groups. This study was institutional review board approved. Results: Forty-seven patients were included and analyzed (24 in the retrospective group and 23 in the prospective group). Patients in the prospective group had an average SBP lowering of 10.83 mm Hg (P = .0035). Thirteen patients (56.5%) met their blood pressure goal of <130/80 mm Hg in the prospective group, compared to 5 patients (20.8%) in the retrospective group (P = .012). One adverse event occurred during this study. Limitations included small sample size and short duration of study. Conclusion: Patients had an average SBP lowering of >10 mm Hg. More patients reached a goal blood pressure of <130/80 mm Hg when managed by pharmacists.
背景:收缩压(SBP)降低10毫米汞柱可显著降低主要心血管疾病事件的风险。药剂师对血压的管理可能有助于这种减少。目的:通过与门诊医生的合作实践协议,评估药师管理高血压的影响。方法:本研究的第一阶段是对2019年10月至2020年8月高血压就诊的医生/护士进行回顾性图表回顾。第二个前瞻性阶段包括2020年12月至2021年1月期间由药剂师管理的高血压患者。主要结果是前瞻性组从研究开始到研究结束时收缩压的变化。次要结局包括两组患者在随访中达到血压目标的患者比例和坚持使用所有降压药物的患者比例。本研究得到了机构审查委员会的批准。结果:纳入并分析47例患者(回顾性组24例,前瞻性组23例)。前瞻性组患者平均收缩压降低10.83 mm Hg (P = 0.0035)。13例患者(56.5%)达到血压目标(P = 0.012)。本研究中发生1例不良事件。局限性包括样本量小,研究时间短。结论:患者平均收缩压降低>10 mm Hg,更多患者达到目标血压
期刊介绍:
For both pharmacists and technicians, jPT provides valuable information for those interested in the entire body of pharmacy practice. jPT covers new drugs, products, and equipment; therapeutic trends; organizational, legal, and educational activities; drug distribution and administration; and includes continuing education articles.